Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Patients With Migraines Found To Have Vitamin Deficiencies

XTALKS VITALS NEWS

Migraine

Physicians are now wondering whether supplementation might be a good treatment option for these young migraine sufferers.

Share this!

June 14, 2016 | by Sarah Massey, M.Sc.

A recent study found that many children and young adults suffering from migraines are deficient in essential nutrients including vitamin D, coenzyme Q10 and riboflavin. Physicians are now wondering whether supplementation might be a good treatment option for these young migraine sufferers.

Tweet: Could vitamin supplements stop #migraines? http://ctt.ec/2PC7r+

“Further studies are needed to elucidate whether vitamin supplementation is effective in migraine patients in general, and whether patients with mild deficiency are more likely to benefit from supplementation,” said Dr. Suzanne Hagler, a Headache Medicine fellow in the division of Neurology at Cincinnati Children's Hospital Medical Center, and lead author on the study. While the study suggests that these patients had vitamin deficiencies, the researchers were unable to determine what effect this finding has on onset or severity of migraine symptoms.

Hagler and her colleagues conducted their study at the Cincinnati Children's Headache Center. Their finders were presented last week at the 58th Annual Scientific Meeting of the American Headache Society.

The Headache Center maintained a database of patients whose baseline levels of multiple nutrients – including vitamin D, riboflavin, coenzyme Q10 and folate – were implicated as a potential cause of migraines. To correct these imbalances, many patients were given both migraine medications and vitamin supplements.



As most patients received a combination treatment as opposed to vitamin supplementation alone, Hagler and her team were unable to make conclusions based on a vitamin’s ability to prevent migraines. The researchers did however, identify some interesting gender-associated vitamin deficiency trends.

Of the patient population studied, the researchers found that girls were more likely to have coenzyme Q10 deficiencies, compared to boys. Young men, on the other hand, were more likely to have a vitamin D deficiency.

Patients suffering from chronic migraines were also more likely to have riboflavin and coenzyme Q10 deficiencies, compared to those with episodic migraines. The researchers were unable to determine whether any of the migraine patients had folate deficiencies.

While previous studies have implicated various vitamin deficiencies as a potential cause for some types of migraines, this research has produced conflicting results. More controlled research must be done to determine whether vitamin supplementation could be an effective treatment for migraines.


Keywords: Migraines, Vitamin Deficiency, Clinical Research


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Gilead’s Newest Hepatitis C Drug Gets FDA Approval

July 21, 2017 - Dominant player in the chronic hepatitis C virus (HCV) market Gilead has received US Food and Drug Administration (FDA) approval for its newest treatment, Vosevi.

Featured In: Pharmaceutical News


Detecting Alzheimer’s Biomarkers in the Blood Could Improve Early Diagnosis

July 20, 2017 - In an effort to improve rates of early diagnosis and intervention, researchers at Washington University in St. Louis have developed a blood test that can detect some of the hallmarks of Alzheimer’s disease.

Featured In: Biotech News


Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know

REGISTER FOR THESE WEBINARS

Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.